Health Catalyst, Inc.
NASDAQ Global SelectTotal Valuation
Health Catalyst, Inc. carries a market capitalization of 166.26M, placing it among publicly traded companies globally. Its enterprise value stands at 151.80M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 166.26M |
| Enterprise Value | 151.80M |
Share Statistics
Health Catalyst, Inc. currently has 73.75M shares outstanding.
| Shares Outstanding | 73.75M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.30, and the price-to-book ratio stands at 0.66.
| PE Ratio | N/A |
| PS Ratio | 0.30 |
| PB Ratio | 0.66 |
| P/TBV Ratio | -2.03 |
| P/FCF Ratio | 4.30 |
| P/OCF Ratio | 4.75 |
Enterprise Valuation
On an enterprise value basis, Health Catalyst, Inc. trades at an EV/EBITDA multiple of 7.38 and an EV/FCF ratio of 3.55.
| EV / Sales | 0.50 |
| EV / EBITDA | 7.38 |
| EV / EBIT | N/A |
| EV / FCF | 3.55 |
Financial Position
Health Catalyst, Inc. maintains a current ratio of 1.69, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 123.48, indicating elevated leverage, while an interest coverage ratio of 0.95 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.69 |
| Quick Ratio | 1.56 |
| Debt / Equity | 123.48 |
| Debt / EBITDA | 8.30 |
| Interest Coverage | 0.95 |
Financial Efficiency
| Return on Equity (ROE) | -103.25 |
| Return on Assets (ROA) | -40.69 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | 915,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Health Catalyst, Inc.'s stock has declined approximately -41.86047% over the past 52 weeks. The 50-day moving average sits at 1.73, while the 200-day moving average is 2.04.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.86047% |
| 50-Day Moving Average | 1.73 |
| 200-Day Moving Average | 2.04 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Health Catalyst, Inc. generated 302.48M in revenue and converted that into -265.26M in net income, yielding earnings per share of -3.74. EBITDA reached 20.56M, while operating income came in at -29.74M.
| Revenue | 302.48M |
| Gross Profit | 150.90M |
| Operating Income | -29.74M |
| Pretax Income | -264.34M |
| Net Income | -265.26M |
| EBITDA | 20.56M |
| EBIT | -29.74M |
| Earnings Per Share (EPS) | -3.74 |
Balance Sheet
Health Catalyst, Inc. holds 108.82M in cash and equivalents against 170.58M in total debt, resulting in a net debt position of 93.50M. Total book value stands at 137.14M, with working capital of 74.70M providing operational flexibility.
| Cash & Cash Equivalents | 108.82M |
| Total Debt | 170.58M |
| Net Debt | 93.50M |
| Equity (Book Value) | 137.14M |
| Book Value Per Share | 1.93 |
| Working Capital | 74.70M |
Cash Flow
Health Catalyst, Inc. produced 18.96M in operating cash flow over the past twelve months. After subtracting -1.99M in capital expenditures, free cash flow totaled 16.97M - equivalent to 0.24 per share.
| Operating Cash Flow | 18.96M |
| Capital Expenditures | -1.99M |
| Free Cash Flow | 16.97M |
| FCF Per Share | 0.24 |
Margins
Health Catalyst, Inc. operates with a gross margin of 49.89, reflecting its pricing power and cost economics. The operating margin of -9.83 and net profit margin of -87.69 provide insight into operational efficiency.
| Gross Margin | 49.89 |
| Operating Margin | -9.83 |
| Pretax Margin | -87.39 |
| Profit Margin | -87.69 |
| EBITDA Margin | 6.80 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 256.63 |
| FCF Yield | 23.27 |
Scores
Health Catalyst, Inc. posts an Altman Z-Score of -7.52, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -7.52 |